IVF

ICSI vs Conventional IVF Fertilization: Who Actually Benefits from ICSI?

October 2026Evidence reviewedEducational guide
ICSI is essential or highly useful in some situations, especially severe male-factor infertility, surgically retrieved sperm, previously frozen oocytes, and prior failed or unexpectedly poor fertilization. But ASRM’s 2026 committee opinion says routine ICSI for every IVF patient without male factor or prior fertilization failure does not improve live birth rates.

What actually happens in each method

With conventional IVF insemination, prepared sperm are placed with each mature egg and fertilization occurs without the embryologist injecting a sperm into the egg. With intracytoplasmic sperm injection (ICSI), an embryologist selects a sperm and injects it through the egg membrane using a microneedle.

Both methods still require mature oocytes, a functioning embryology laboratory, and successful embryo development after fertilization. ICSI solves a fertilization-access problem; it does not fix every cause of poor embryo development.

Situations where ICSI is commonly appropriate

Where routine ICSI has not shown a live-birth benefit

ASRM’s 2026 review concludes that routine ICSI is not recommended solely because of unexplained infertility, advanced maternal age, diminished ovarian reserve, low oocyte yield, or planned PGT-A when male factor is absent.

Some studies show that ICSI can reduce the chance of complete fertilization failure in particular groups, but preventing a rare fertilization event is not the same as proving more live births overall. That distinction is easy to lose when clinics quote only fertilization rates.

ICSI and PGT are not automatically linked

ICSI was historically recommended for PGT partly to reduce sperm-DNA contamination with older molecular techniques. With contemporary testing, ASRM reports no evidence that ICSI improves euploidy or live birth rates for PGT-A in patients without male factor.

PGT-M can be different because the laboratory may want to minimize outside DNA when testing for a specific inherited condition. Ask the genetics laboratory whether ICSI is required for your exact test rather than assuming all PGT cycles need it.

Questions to ask before paying for ICSI

The decision happens at fertilization, not at embryo transfer

Conventional IVF and ICSI differ in how sperm and egg are brought together. They do not represent two different embryo-transfer methods, and ICSI does not automatically create a genetically “better” embryo. Once normal fertilization occurs, embryo culture proceeds similarly.

SituationWhat current evidence/guidance suggests
Clear male-factor infertilityICSI is a well-established method to overcome impaired sperm number, motility or function.
Prior failed or unexpectedly poor fertilization with conventional IVFICSI can reduce the risk of repeating the same fertilization problem.
Previously frozen oocytesICSI is the established fertilization approach in most programs.
PGT-MICSI may be used to reduce risk of DNA contamination affecting the genetic test.
PGT-A only, no male factorICSI has not been shown to improve live birth, euploidy rate or embryo number solely because PGT-A is planned.
Advanced maternal age / low egg yield, no male factorRoutine ICSI has not shown a live-birth benefit simply for these indications.

Fertilization rate is not the same as live birth

This distinction is easy to miss when comparing clinic brochures. An intervention may change how many eggs fertilize without improving how many patients ultimately take home a baby. The 2026 ASRM committee opinion specifically concludes that routine ICSI for non-male-factor infertility does not improve live-birth rates.

Ask for the reason: “What is the specific indication for ICSI in our cycle?” A concrete answer such as severe male factor, prior fertilization failure, frozen oocytes or PGT-M is more useful than “we use it for everyone.”

What about split IVF/ICSI?

Some laboratories inseminate sibling oocytes by both methods in selected situations. This can provide information about fertilization performance and reduce the risk of total fertilization failure, but it requires enough mature oocytes to divide meaningfully and is not appropriate for every patient. Ask whether the clinic uses split insemination and in what circumstances.

ICSI does not bypass egg quality

ICSI can help sperm enter the egg; it does not correct age-related aneuploidy, poor oocyte competence, mitochondrial dysfunction or many causes of embryo arrest. When fertilization is normal but embryos stop developing, automatically adding or repeating ICSI may not address the underlying bottleneck.

Costs and laboratory tradeoffs

ICSI adds embryology work and usually an additional fee. It also requires removing surrounding cumulus cells before injection, which means the embryologist can assess nuclear maturity but conventional sperm-oocyte interaction is bypassed. These facts do not make ICSI “bad”; they are reasons to use it when it solves a defined problem rather than as an automatic upgrade.

Questions for the clinic

  • What is our ICSI indication?
  • Would conventional insemination be reasonable?
  • Do you offer split insemination?
  • How often does total fertilization failure occur here?

Questions for the lab

  • How many mature oocytes are expected?
  • How is prior fertilization history weighed?
  • Does planned genetic testing truly require ICSI?
  • Is there an added laboratory fee?

How to read your fertilization report

The next morning, clinics commonly report the number of mature oocytes and the number showing normal fertilization, usually defined by two pronuclei (2PN). A lower-than-expected 2PN rate can prompt a discussion about sperm, oocyte maturity, laboratory factors and whether ICSI should be used in a future cycle. One abnormal result should be interpreted in the context of how many mature eggs were available.

2026 update: ASRM's current committee opinion recommends against routine ICSI for non-male-factor infertility and specifically notes no demonstrated live-birth benefit for unexplained infertility, diminished ovarian reserve, advanced maternal age, low oocyte yield, or PGT-A alone.

Frequently asked questions

Does ICSI make better embryos?

Not necessarily. ICSI changes how sperm enters the egg; it does not guarantee normal fertilization, blastocyst development, euploidy, implantation, or live birth.

Is ICSI always needed with PGT-A?

No. ASRM’s 2026 review does not recommend ICSI solely for PGT-A when male factor is absent.

Is ICSI used with frozen eggs?

Yes. ICSI is the established fertilization approach after oocyte thaw because freezing changes the surrounding structures and conventional insemination is less suitable.

Related ConceiveGuide articles

Sources and evidence checked

Medical disclaimer: This article is for general educational purposes and is not medical advice, diagnosis, or a treatment recommendation. Fertility evaluation and treatment should be individualized with a qualified reproductive endocrinologist, reproductive urologist, gynecologic surgeon, or other appropriate clinician.